Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tropisetron for prevention of rebound pain and anxiety after upper extremity surgery under brachial plexus anesthesia
ChiCTR2300069994Phase 4Not yet recruiting
- Sponsor
- Xiangyang Central Hospital
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tropisetron in postoperative pain and anxiety disorder (2 arms), sponsored by Xiangyang Central Hospital. Primary endpoints: Postoperative pain score and Postoperative anxiety score. Planned start Apr 2023; status: not yet recruiting.
02
Drugs
tropisetron
03
Conditions
postoperative painanxiety disorder
Beyond the preview
Go deeper on ChiCTR2300069994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069994.